Colgate-Palmolive (NYSE:CL) Shares Sold by Glenview Trust co

Glenview Trust co reduced its position in Colgate-Palmolive (NYSE:CL) by 7.2% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 14,207 shares of the company’s stock after selling 1,100 shares during the quarter. Glenview Trust co’s holdings in Colgate-Palmolive were worth $1,292,000 as of its most recent filing with the SEC.

Several other institutional investors also recently bought and sold shares of CL. Swedbank AB boosted its position in shares of Colgate-Palmolive by 1.4% during the 3rd quarter. Swedbank AB now owns 2,950,059 shares of the company’s stock worth $306,246,000 after purchasing an additional 40,324 shares in the last quarter. OneDigital Investment Advisors LLC boosted its position in shares of Colgate-Palmolive by 23.8% during the 3rd quarter. OneDigital Investment Advisors LLC now owns 14,829 shares of the company’s stock worth $1,539,000 after purchasing an additional 2,847 shares in the last quarter. Natixis Advisors LLC boosted its position in shares of Colgate-Palmolive by 15.5% during the 3rd quarter. Natixis Advisors LLC now owns 386,681 shares of the company’s stock worth $40,141,000 after purchasing an additional 51,991 shares in the last quarter. Thrivent Financial for Lutherans boosted its position in shares of Colgate-Palmolive by 39.8% during the 3rd quarter. Thrivent Financial for Lutherans now owns 90,023 shares of the company’s stock worth $9,345,000 after purchasing an additional 25,645 shares in the last quarter. Finally, Quest Partners LLC boosted its position in shares of Colgate-Palmolive by 69.6% during the 3rd quarter. Quest Partners LLC now owns 31,829 shares of the company’s stock worth $3,304,000 after purchasing an additional 13,066 shares in the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several brokerages have commented on CL. UBS Group decreased their target price on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a research report on Monday, February 3rd. Raymond James reiterated an “outperform” rating and issued a $105.00 price objective (down from $110.00) on shares of Colgate-Palmolive in a research report on Monday, February 3rd. Piper Sandler decreased their price objective on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research report on Monday, January 6th. TD Cowen decreased their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research report on Wednesday, January 8th. Finally, Barclays decreased their price objective on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research report on Friday, January 17th. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and eleven have assigned a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $101.72.

Colgate-Palmolive Trading Up 1.0 %

NYSE CL opened at $90.72 on Tuesday. The company has a 50-day moving average of $89.09 and a 200-day moving average of $94.56. The company has a market cap of $73.62 billion, a P/E ratio of 25.77, a P/E/G ratio of 4.20 and a beta of 0.40. Colgate-Palmolive has a 12 month low of $85.32 and a 12 month high of $109.30. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the prior year, the firm posted $0.87 earnings per share. As a group, equities analysts predict that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.